• Home
  • About Us
  • Subscribe
  • Advertise
  • Newsroom
  • Sign In
  • Create Account
  • Sign Out
  • My Account
  • Current Issue
    • Latest News
    • Special Report
    • Up Close
    • Opinion
  • News by Sector
    • Real Estate & Construction
    • Banking & Finance
    • Health Care
    • Education & Talent
    • North Idaho
    • Technology
    • Manufacturing
    • Retail
    • Government
  • Roundups & Features
    • Calendar
    • People
    • Business Licenses
    • Q&A Profiles
    • Cranes & Elevators
    • Retrospective
    • Insights
    • Restaurants & Retail
  • Supplements & Magazines
    • Book of Lists
    • Building the INW
    • Market Fact Book
    • Economic Forecast
    • Best Places to Work
    • Partner Publications
  • E-Edition
  • Journal Events
    • Elevating the Conversation
    • Workforce Summit
    • Icons
    • Women in Leadership
    • Rising Stars
    • Best Places to Work
    • People of Influence
    • Business of the Year Awards
  • Podcasts
  • Sponsored
Home » Selkirk Pharma expands vision for West Plains plant

Selkirk Pharma expands vision for West Plains plant

Plans on file with city show startup intends to employ 320 people

July 16, 2020
Natasha Nellis

Selkirk Pharma Inc.’s envisioned manufacturing plant on the West Plains will be more than double the size originally indicated, emerging details show. 

The Spokane-based injectable-drug manufacturing and packaging startup could break ground on the project as soon as next month, though a specific timeline is still unclear.  

Planning documents filed with the city of Spokane now show the two-story structure to be located at 9110 W. Granite eventually will accommodate more than 300 employees in 147,600 square feet of office, manufacturing, and warehouse space. An initial building permit application listed a 63,000-square-foot building. 

The company has applied for a permit to begin site grading and utility work on the planned facility. Work could begin next month, according to environmental documents filed with the city of Spokane in early March. Other planning documents filed at that time show the company plans to complete the site work and building envelope by December 2021, with some tenant improvements being deferred until a later date.

However, Selkirk Pharma CEO Patrick Haffey told the Journal in late March that the construction timeline for the company’s planned facility was thrown into uncertainty due to disruptions related to COVID-19.

Reached earlier this month, John Bertagnolli, Selkirk Pharma’s vice president of commercial operations, declined to comment on the project. 

The site work and foundation portion of the project have a construction value of $4.5 million, permit information shows. The project previously was estimated to be valued at $30 million in all. A valuation of the expanded project isn’t included in the updated plans. 

Upon completion, the environmental documents show the facility is expected to employ about 100 workers, plans indicate. Once tenant improvements are complete, the facility will employ about 320 workers.

Selkirk Pharma purchased the vacant 16.4-acre development site at the northeast corner of Granite Avenue and Flint Road in late September for $1.3 million, according to Spokane County Assessor’s Office records. 

Spokane-based Bernardo|Wills Architects PC is the project architect. Bouten Construction Co. is the general contractor. Coffman Engineers Inc., of Spokane, and the Spokane office of DCI Engineers provided engineering services.

Selkirk Pharma’s website states the company is hiring people with pharmaceutical industry experience in engineering, validation, product management, manufacturing, analytical and microbiological quality control, and administration.

The startup raised $9 million in new angel funding in late March, the Journal previously reported. According to proprietary market data software subscription platform PitchBook, the company previously had received $1.7 million in angel funding in 2018.

The company currently has about 10 employees, according to PitchBook.

Selkirk Pharma was founded in 2018 by a team of physicians and pharmaceutical industry leaders and currently is located at 827 W. First downtown.

    Latest News Real Estate & Construction Health Care Manufacturing
    • Related Articles

      Young Selkirk Pharma envisions big facility on West Plains

      Selkirk Pharma completes its first plant

      Mullen Technologies seeks more time for West Plains plant

    • Related Products

      Market Fact Book PDF

      Book of Lists Hard Copy

      Book of Lists - Digital Version - Top 20 Inland Northwest SBA Lenders

    Natasha Nellis

    2019 Rising Stars: Mary McDirmid

    More from this author
    Daily News Updates

    Subscribe today to our free E-Newsletters!

    SUBSCRIBE

    Featured Poll

    How was the first half of the year for your business?

    Popular Articles

    • Stephanie vigil web
      By Karina Elias

      Catching up with: former news anchor Stephanie Vigil

    • 40.13 fc art
      By Tina Sulzle

      $165 million development planned at CDA National Reserve

    • Binw davebusters (72) web
      By Journal of Business Staff

      Dave & Buster's to open Spokane Valley venue in August

    • Stcu ceo lindseymyhre web
      By Journal of Business Staff

      STCU names new president, CEO

    • Centennial lofts
      By Erica Bullock

      Large Spokane Valley residential project advances

    • News Content
      • News
      • Special Report
      • Up Close
      • Roundups & Features
      • Opinion
    • More Content
      • E-Edition
      • E-Mail Newsletters
      • Newsroom
      • Special Publications
      • Partner Publications
    • Customer Service
      • Editorial Calendar
      • Our Readers
      • Advertising
      • Subscriptions
      • Media Kit
    • Other Links
      • About Us
      • Contact Us
      • Journal Events
      • Privacy Policy
      • Tri-Cities Publications

    Journal of Business BBB Business Review allianceLogo.jpg CVC_Logo-1_small.jpg

    All content copyright ©  2025 by the Journal of Business and Northwest Business Press Inc. All rights reserved.

    Design, CMS, Hosting & Web Development :: ePublishing